Biochemical validation of the enriched signaling pathways identified in the KEGG analysis, such as the Neurotrophin signaling pathway, PI3K-AKT signaling pathway, and Alzheimer’s disease pathway, strengthens our findings. Here, AKT1 is linked to early-onset autosomal dominant Alzheimer disease.